Livelsberger Financial Advisory »

Anixa Biosciences shares owned by Livelsberger Financial Advisory

Quarter-by-quarter ownership of Anixa Biosciences (ANIX) shares owned by Livelsberger Financial Advisory from 13F filings

Historical chart of Livelsberger Financial Advisory investment in Anixa Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Anixa Biosciences held by Livelsberger Financial Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anixa Biosciences by Livelsberger Financial Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3k 1.6k 3.88

More positions owned by Livelsberger Financial Advisory

T. Rowe Price Health Sciences Mfa (PRHSX)
Harbor Capital Appreciation Inv Mfa (HCAIX)
Oakmark Investor Mfa (OAKMX)
Franklin Income A1 MFF (FKINX)
Eaton Vance Income Fund Of Boston A MFF (EVIBX)
T. Rowe Price Capital Appreciation Mfa (PRWCX)
Rydex Biotechnology A MPL (RYBOX)
Cohen & Steers Realty Shares L Mfa (CSRSX)
Schwab Value Advantage Money Inv MMN (SWVXX)
Eaton Vance National Municipal Income A MFF (EANAX)
Selected American Shares S Mfa (SLASX)
Invesco Value Municipal Cem (IIM)
Rydex Basic Materials A MPL (RYBMX)
Blackrock Municipal Inco Cem (BFK)
Rydex Transportation A MPL (RYTSX)

View all positions for Livelsberger Financial Advisory

Top funds holding Anixa Biosciences

Vanguard Group
UBS Group
Mission Wealth Management
Long Focus Capital Management
Bank of New York Mellon
Citadel Advisors
Jane Street
Cambridge Investment Research Advisors
CI Private Wealth
Gemmer Asset Management
Dimensional Fund Advisors
Tyler-Stone Wealth Management
Raymond James & Associates
Bank of America Corporation
Sawtooth Asset Management

View all funds holding Anixa Biosciences